Literature DB >> 35012907

[Tumor necrosis factor-α promotes osteoclast differentiation via sialylation in mice].

X Li1, W Zhang2.   

Abstract

OBJECTIVE: To explore the mechanism through which tumor necrosis factor-α (TNF-α) promotes osteoclast differentiation.
METHODS: Bilateral knee joint samples were collected from 4-month-old wild-type mice and TNF-α transgenic mice for CT scan analysis, TRAP staining and sialic acid staining analysis. The osteoclast precursor (RAW264.7) cells were cultured for 3 days in induction medium in the presence of vehicle, TNF-α, or TNF-α and sialidase, and were then examined with RT-qPCR, TRAP staining, and sialic acid immunofluorescence co-localization staining. Bone marrow-derived macrophages isolated from the wild-type mice and TNF-α transgenic mouse and cultured in induction medium with or without the addition of sialidase, and TRAP and sialic acid staining was performed after 3 days of cell culture.
RESULTS: TRAP staining showed that the number of osteoclasts increased significantly in TNF-α transgenic mice as compared with the wild-type mice (P < 0.0001), and micro-CT analysis revealed significant reductions of BV/TV, Tb.N, and Tb.Th in TNF-α transgenic mice (P < 0.001). The osteoclasts in TNF-α transgenic mice also showed a significantly increased expression of sialic acid (P=0.004). In the cell experiment, RAW264.7 cells cultured with TNF-α showed a significantly higher expression of sialic acid (P < 0.0001) and a greater osteoclast formation rate (P=0.0007) than the the control cells, while the addition of sialidase significantly reduced sialic acid expression, osteoclast formation rate and TRAP mRNA level in TNF-α-treated cells (P < 0.0001). Similarly, in the bone marrow-derived macrophages, sialic acid expression and osteoclast formation rate were significantly increased by incubation with TNF-α (P < 0.0001), but the increments were obviously reduced by addition of sialidase in the medium (P < 0.0001).
CONCLUSION: TNF-α can promote the differentiation and activity of osteoclasts by increasing the sialylation level in the osteoclasts.

Entities:  

Keywords:  osteoclasts; sialylation; tumor necrosis factor-α

Mesh:

Substances:

Year:  2021        PMID: 35012907      PMCID: PMC8752434          DOI: 10.12122/j.issn.1673-4254.2021.12.03

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  27 in total

1.  Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2011-09       Impact factor: 4.313

2.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

3.  Osteoclasts are essential for TNF-alpha-mediated joint destruction.

Authors:  Kurt Redlich; Silvia Hayer; Romeo Ricci; Jean-Pierre David; Makiyeh Tohidast-Akrad; George Kollias; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.

Authors:  Kurt Redlich; Silvia Hayer; Andrea Maier; Colin R Dunstan; Makiyeh Tohidast-Akrad; Susanne Lang; Birgit Türk; Peter Pietschmann; Wolfgang Woloszczuk; Silva Haralambous; George Kollias; Günter Steiner; Josef S Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2002-03

5.  Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

Authors:  S E Lee; W J Chung; H B Kwak; C H Chung; K B Kwack; Z H Lee; H H Kim
Journal:  J Biol Chem       Date:  2001-10-23       Impact factor: 5.157

Review 6.  RANK/RANKL: regulators of immune responses and bone physiology.

Authors:  Andreas Leibbrandt; Josef M Penninger
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

8.  Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE.

Authors:  D Kim; R E Mebius; J D MacMicking; S Jung; T Cupedo; Y Castellanos; J Rho; B R Wong; R Josien; N Kim; P D Rennert; Y Choi
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

9.  Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.

Authors:  Inês P Perpétuo; Joana Caetano-Lopes; Ana Maria Rodrigues; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411

10.  Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.

Authors:  Kazuhiro Yokota; Kojiro Sato; Takashi Miyazaki; Yoshimi Aizaki; Shinya Tanaka; Miyoko Sekikawa; Noritsune Kozu; Yuho Kadono; Hiromi Oda; Toshihide Mimura
Journal:  Arthritis Rheumatol       Date:  2021-05-27       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.